Benchmark Upgrades CryoLife (CRY) to Buy Due to Long-Term Catalysts
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Price: $17.38 -1.64%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Benchmark upgraded shares of CryoLife (NYSE: CRY) today to a Buy rating from its previous rating of Hold and is maintaining its price target of $6.50.
The firm is also raising its 2011 EPS estimate to $0.39 as the company earned $0.21 per share in the first half of the year.
Benchmark believes that a conservative multiple is accurate until CryoLife generates more substantial organic growth.
For more ratings news on CryoLife click here and for the rating history of CryoLife click here.
Shares of CryoLife closed at $5.42 yesterday.
The firm is also raising its 2011 EPS estimate to $0.39 as the company earned $0.21 per share in the first half of the year.
Benchmark believes that a conservative multiple is accurate until CryoLife generates more substantial organic growth.
For more ratings news on CryoLife click here and for the rating history of CryoLife click here.
Shares of CryoLife closed at $5.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Jefferies Upgrades Minerva Neurosciences (NERV) to Buy
- Desjardins Upgrades PRO REIT (PRV-U:CN) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
